Ascendiant Capital Markets

Ascendiant Capital Markets is a boutique investment bank and broker-dealer headquartered in Jupiter, Florida, offering corporate finance, M&A advisory, equity research, institutional sales and market making. Its research concentrates on healthcare and technology companies.

Company history

Co-founders Bradley Wilhite and Mark Bergendahl, who had earlier started and operated businesses including Odyssey Sports, later sold to Callaway Golf, launched the first Ascendiant entity, Ascendiant Capital Group, in 2001. The broker-dealer Ascendiant Capital Markets, LLC was organized in Nevada in 2010. Its main office is in Jupiter, Florida, with a further office in Irvine, California.

  1. 2001First entity, Ascendiant Capital Group, launched
  2. 2010Broker-dealer Ascendiant Capital Markets, LLC organized in Nevada
  3. 2014Adopts three-tier Buy/Hold/Sell rating system

Research

Ascendiant's two-analyst research team covers companies in healthcare (biotech, life sciences, medical devices), technology, energy, consumer, media and internet as of 2026; it rated 54 companies as of July 2025, 53 of them Buy. Since January 31, 2014 it has rated stocks Buy (total return of 15% or more), Hold (-15% to +15%) or Sell over 12 months, replacing a scale that included Strong Buy and Speculative Buy.

Coverage12M

Stocks
38
Ratings
125
Price targets
6
Median upside
+134.9%
Upgrades
0
Downgrades
0
Initiations
0
Reiterations
125
Targets raised
1
Targets cut
1
  • Positive100%38
  • Neutral0%0
  • Negative0%0

Sectors

  • Health Care63%
  • Information Technology21%
  • Industrials5%
  • Consumer Staples3%
  • Materials3%
  • Consumer Discretionary3%
  • Communication Services3%

Ratings

  • Buy100%

Listing

  • United States92%
  • Denmark3%
  • Singapore3%
  • Israel3%

Activity24M

RatingsPrice targets23
Oct 2024 · Ratings 0 · Price targets 0Nov 2024 · Ratings 9 · Price targets 0Dec 2024 · Ratings 15 · Price targets 0Jan 2025 · Ratings 0 · Price targets 0Feb 2025 · Ratings 2 · Price targets 0Mar 2025 · Ratings 7 · Price targets 0Apr 2025 · Ratings 22 · Price targets 0May 2025 · Ratings 11 · Price targets 0Jun 2025 · Ratings 16 · Price targets 0Jul 2025 · Ratings 0 · Price targets 0Aug 2025 · Ratings 4 · Price targets 0Sep 2025 · Ratings 15 · Price targets 0Oct 2025 · Ratings 13 · Price targets 1Nov 2025 · Ratings 7 · Price targets 0Dec 2025 · Ratings 22 · Price targets 1Jan 2026 · Ratings 1 · Price targets 0Feb 2026 · Ratings 1 · Price targets 1Mar 2026 · Ratings 6 · Price targets 1Apr 2026 · Ratings 19 · Price targets 1May 2026 · Ratings 6 · Price targets 0Jun 2026 · Ratings 20 · Price targets 0Jul 2026 · Ratings 0 · Price targets 0Aug 2026 · Ratings 15 · Price targets 1Sep 2026 · Ratings 10 · Price targets 0
Oct '24Oct '25Sep '26

Most covered24M

StockRatingTargetActionsLast action
DUOTDuos Technologies Group, Inc.Buy$1711Sep 14
GNSSGenasys Inc.Buy$59Aug 28
RNXTRenovoRx, Inc.Buy9Aug 28
GRIGRI Bio, Inc.Buy8Aug 21
LUCDLucid Diagnostics Inc.Buy8Aug 27
PAVMPAVmed Inc.Buy8Aug 27
QUBTQuantum Computing, Inc.Buy$408Aug 26
SURGSurgePays, Inc.Buy$108Sep 14
ALZNAlzamend Neuro, Inc.Buy7Aug 19
AMTXAemetis, Inc.Buy7Aug 20

Analysts24M

  • Edward WooGNSS · QUBT · SNYR3

Recent actions

StockRating actionRatingTargetDate
Allarity Therapeutics, Inc.ALLRReiterateBuySep 16
Banzai International, Inc.PARAReiterateBuySep 14
SurgePays, Inc.SURGReiterateBuySep 14
Duos Technologies Group, Inc.DUOTReiterateBuySep 14
Knightscope, Inc.KSCPReiterateBuySep 14
NextTrip, Inc.NTRPReiterateBuySep 14
Cerenome, Inc.CNSYReiterateBuySep 11
Outlook Therapeutics, Inc.OTLKReiterateBuySep 11
Pro-Dex, Inc.PDEXReiterateBuySep 11
LiqTech International, Inc.LIQTReiterateBuySep 4
Genasys Inc.GNSSReiterateBuy$5.50$5Aug 28

Similar coverage12M

References

  1. Ascendiant Capital Markets, LLC - Homeascendiant.com
  2. Equity Research - Ascendiant Capital Marketsascendiant.com
  3. Ascendiant Capital Markets, LLC - FINRA BrokerCheckbrokercheck.finra.org
  4. Ascendiant research report on Maison Solutions (September 2025)cdn.aelieve.com
  5. Ascendiant coverage initiation on PDEX with prior rating system (2017)ascendiant.com